Eribulin Mesylate Injection
Product Images NDC 60505-6289

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 60505-6289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Eribulin-spl-carton-label (Eribulin Spl Carton Label)

Packaging label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution for intravenous use. The single-dose vial is labeled for Apotex Corp. and includes usage cautions such as discard unused portions and storage instructions not to freeze or refrigerate. The label notes it as a cytotoxic agent with a concentration of 0.5 mg/mL eribulin mesylate in solution.*

FDA Label Image

Eribulin-spl-fig-1 (Eribulin Spl Fig 1)

Kaplan-Meier survival curve comparing eribulin mesylate injection to a control group. The graph plots the proportion of patients surviving over time in months, with survival decreasing from 1.0 to 0. The eribulin mesylate group (N=508) and control group (N=254) are represented by separate lines, with patient numbers at risk indicated below the time axis.*

FDA Label Image

Eribulin-spl-fig-2 (Eribulin Spl Fig 2)

A survival probability Kaplan-Meier curve comparing Eribulin Mesylate and Dacarbazine over 45 months. The graph plots survival probability on the y-axis and survival time in months on the x-axis, showing higher survival probabilities for Eribulin Mesylate than for Dacarbazine. A table below presents the number of subjects at risk for both treatments at various time points.*

FDA Label Image

Eribulin-spl-structure (Eribulin Spl Structure)

Chemical structure of eribulin mesylate showing the molecular arrangement of atoms including carbon, hydrogen, oxygen, nitrogen, and the mesylate group (CH3-SO3H). The diagram displays the complex ring system and stereochemistry characteristic of this active pharmaceutical ingredient.*

FDA Label Image

Eribulin-spl-vial-label (Eribulin Spl Vial Label)

Label for Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vial for intravenous use. The label includes storage instructions, cautionary statements, and manufacturer information for Apotex Corp. The NDC number 60505-6289 is displayed alongside a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.